HNRNPA2B1 and hypoparathyroidism-retardation-dysmorphism syndrome: Finally, Spearman correlation analysis revealed that the expression of HNRNPA2B1 was significantly correlated with the serum RF level in patients with HRD (r = 0.975, P < 0.01) (Figure 4e).